a5471d
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of October 2020
Commission
File Number: 001-11960
AstraZeneca PLC
1
Francis Crick Avenue
Cambridge
Biomedical Campus
Cambridge
CB2 0AA
United
Kingdom
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F X Form 40-F __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ______
Indicate
by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes __
No X
If
“Yes” is marked, indicate below the file number
assigned to the Registrant in connection with Rule 12g3-2(b):
82-_____________
AstraZeneca PLC
INDEX
TO EXHIBITS
29 October 2020 07:00 GMT
Non-Executive Board Appointment
AstraZeneca PLC today announced that with effect from 1 November
2020, Diana Layfield is appointed as a Non-Executive
Director.
Leif Johansson, Chairman of AstraZeneca, said: "We are delighted
that Diana is joining AstraZeneca's Board. Her broad international
business experience, which began in the pharmaceutical and biotech
sector, encompasses leadership roles in international banking,
global technology and a fintech start-up. Diana's expertise in
delivering innovation at scale coupled with her passion for life
sciences will be of great value to AstraZeneca as we continue to
grow and invest for the future."
Diana Layfield is President, EMEA Partnerships at Google, driving
technology transformation and solutions across all Google product
areas for major partners in the region. She is also Vice-President,
'Next Billion Users' & Product Management, leading the
development of products and services for future Google users,
primarily in emerging markets. Prior to Google, Diana held senior
positions at Standard Chartered Bank, including Chief Executive
Officer, Africa Region; COO Wholesale Banking; and Group Head of
Strategy & Corporate Development. Before joining Standard
Chartered in 2004, she was Chief Executive Officer of a start-up
technology company. Diana was previously a consultant at McKinsey
& Co, becoming a sector lead for Healthcare and Life Sciences
and advising pharmaceutical, biotech and other life sciences
companies.
Diana has been a Non-Executive Director of Aggreko plc since 2012
and sits on the Board's Audit, Ethics and Corporate Responsibility,
and Nomination Committees. She is a Council Member of the London
School of Hygiene & Tropical Medicine.
Diana has a BA degree from the University of Oxford and an MA in
Public Administration and International Economics from Harvard
University.
Except as set out above, no disclosure obligations arise under
paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's
Listing Rules in respect of this appointment
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global,
science-led biopharmaceutical company that focuses on the
discovery, development and commercialisation of prescription
medicines, primarily for the treatment of diseases in three therapy
areas - Oncology, Cardiovascular, Renal & Metabolism, and
Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca
operates in over 100 countries and its innovative medicines are
used by millions of patients worldwide. Please
visit astrazeneca.com and
follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please
click here.
For Media contacts, click here.
Adrian Kemp
Company Secretary
AstraZeneca PLC
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date:
29 October
2020
|
By: /s/
Adrian Kemp
|
|
Name:
Adrian Kemp
|
|
Title:
Company Secretary
|